These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1684869)

  • 1. Simple methodology of assessment of analgesics' addictive potential in mice.
    Pchelintsev MV; Gorbacheva EN; Zvartau EE
    Pharmacol Biochem Behav; 1991 Aug; 39(4):873-6. PubMed ID: 1684869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative comparison of ohmefentanyl isomers induced conditioning place preference in mice.
    Guo GW; Liu ZH; Jin WQ; Zhang HP; Chen XJ; Zhu YC; Chi ZQ
    Life Sci; 2001 Apr; 68(21):2383-90. PubMed ID: 11350009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The additive index--a new preclinical indicator of the addictive potential of analgesic agents].
    Evartau EE; Kovalenko VS
    Farmakol Toksikol; 1987; 50(4):69-71. PubMed ID: 3666120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference.
    Shoblock JR; Wichmann J; Maidment NT
    Neuropharmacology; 2005 Sep; 49(4):439-46. PubMed ID: 15919100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.
    Smith MA; Chisholm KA; Bryant PA; Greene JL; McClean JM; Stoops WW; Yancey DL
    Psychopharmacology (Berl); 2005 Aug; 181(1):27-37. PubMed ID: 15778888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of morphine and morphine-like analgesics on susceptibility to seizures in mice.
    Czuczwar SJ; Frey HH
    Neuropharmacology; 1986 May; 25(5):465-9. PubMed ID: 2874517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motivational properties of buprenorphine as assessed by place and taste conditioning in rats.
    Gaiardi M; Bartoletti M; Bacchi A; Gubellini C; Babbini M
    Psychopharmacology (Berl); 1997 Mar; 130(2):104-8. PubMed ID: 9106906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats.
    Terner JM; Barrett AC; Grossell E; Picker MJ
    Psychopharmacology (Berl); 2002 Sep; 163(2):183-93. PubMed ID: 12202965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL; Bigelow GE; Bickel WK; Liebson IA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD; Dykstra LA
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent reinforcing effects of dihydroetorphine in rats.
    Martin TJ; Kim SA; Harris LS; Smith JE
    Eur J Pharmacol; 1997 Apr; 324(2-3):141-5. PubMed ID: 9145764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The psychopharmacology of narcotics: a preclinical study].
    Evartau EE
    Eksp Klin Farmakol; 1992; 55(5):65-8. PubMed ID: 1305461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine.
    Zadina JE; Nilges MR; Morgenweck J; Zhang X; Hackler L; Fasold MB
    Neuropharmacology; 2016 Jun; 105():215-227. PubMed ID: 26748051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical observations of agonist-antagonist analgesic dependence.
    Peachey JE
    Drug Alcohol Depend; 1987 Dec; 20(4):347-65. PubMed ID: 2894289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Full ยต-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
    van Niel JC; Schneider J; Tzschentke TM
    Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.
    Oliveto AH; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):8-18. PubMed ID: 1850479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.